For KPJ, Maybank Investment Bank Research projects EPS growth of 4% in FY20E and 10% in FY21E, underpinned by its fast bed capacity growth of 8% in FY20E (FY19E: +3%).
KUALA LUMPUR: Maybank Investment Bank Research has Buy calls on KPJ Healthcare
and Kossan in the healthcare segment.
It said on Tuesday that for KPJ, it projects EPS growth of 4% in FY20E and 10% in FY21E, underpinned by its fast bed capacity growth of 8% in FY20E (FY19E: +3%).
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
